Hydroxychloroquine reduces time to clinical recovery when treating COVID-19 disease patients:

The accelerating debate about the clinical benefit of treating COVID-19 disease patients with hydroxychloroquine became a little bit clearer with a new study.

Previous studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in vitro. 

As a derivative of CQ, hydroxychloroquine (HCQ) is reported to offer similar therapeutic effects, but with fewer adverse effects. 

However, the scientific evidence regarding this antimalarial drug efficacy in COVID-19 patients is limited, since it is a new disease. 

A new, small, non-peer-reviewed clinical study published on March 31, 2020, evaluated the efficacy of hydroxychloroquine (HCQ) in the treatment of patients with COVID-19 in China. 

From February 4 to February 28, 2020, 62 patients suffering from COVID-19 were diagnosed and admitted to the Renmin Hospital of Wuhan University, located in China.

All participants were randomized in a parallel-group trial #ChiCTR2000029559, 31 patients were assigned to receive an additional 5-day HCQ (400 mg/d) treatment, Time to clinical recovery (TTCR), clinical characteristics, and radiological results were assessed at baseline and 5 days after treatment to evaluate the effect of HCQ. 

Read the full article here: https://www.precisionvaccinations.com/hydroxychloroquine-reduces-time-clinical-recovery-when-treating-covid-19-disease-patients

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »